Table 3 Comparison of proliferation and IC50 values (µM) of temozolomide (TMZ) treatment (48 h exposition) in primary glioblastoma cells isolated from patient´s samples (GBM26, GBM43 and GBM59). Endpoint detection was performed using WST-1 analysis